Brunner’s Gland Hyperplasias and Hamartomas in Association with Helicobacter pylori

Table 2

Association between the proliferative lesions of Brunner’s gland and the variables.

Variables		Type of the Proliferative Lesion of BG				Statistical result
		Hamartoma		Hyperplasia
		n	%	n	%	p
Gender	Female	4	80	5	38.46	0.294
	Male	1	20	8	61.54
Gastritis Status	Chronic gastritis	3	60	8	61.54	0.676
	Active chronic gastritis	2	40	5	38.46
Lymphoid Hyperplasia	No	3	60	11	84.62	0.533
	Yes	2	40	2	15.38
Foveolar Hyperplasia	No	5	100	12	92.31	0.722
	Yes	0	0	1	7.69
Gastric Mucosa Inflammation	No	0	0	0	0	-
	Yes	5	100	13	100
Gastric Mucosa Activation	No	3	60	6	46.15	0.5
	Yes	2	40	7	53.85
Gastric Mucosa Metaplasia	No	4	80	13	100	0.278
	Yes	1	20	0	0
Gastric Mucosa Atrophy	No	4	80	13	100	0.278
	Yes	1	20	0	0
Gastric Mucosa H. pylori	No	2	40	4	30.77	0.561
	Yes	3	60	9	69.23
Duodenitis; Status	Chronic duodenitis	5	100	11	84.62	0.51
	Active chronic duodenitis	0	0	2	15.38
Site of the Proliferative Lesion of BG	Anterior bulbus	4	80	3	23.08	0.046
	Posterior bulbus	1	20	2	15.38
	On both sides	0	0	8	61.54
Variables		Type of the Proliferative Lesion of BG
		n	Mean Min. Max.		SD	p
Age	BG hamartoma	5	68.6 52 85		11.93	0.002
	BG hyperplasia	13	40.92 16 63		13.97
Lesion diameter (mm)	BG hamartoma	5	12.8 5 30		9.88	0.0001
	BG hyperplasia	13	3.07 2 4		0.8

BG = Brunner’s gland, f = Fisher’s exact test, U = Mann-Whitney U test, H. pylori = Helicobacter pylori, and SD = standard deviation.